Belgium· BE-AMP-SAM145293-00
Spasmomen 20 mg
A otilonium bromide product containing otilonium bromide, registered in Belgium by Menarini Benelux. The same ATC class is registered in 2 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Otilonium bromide is registered in 2 of 19 countries.
Countries holding a registration under ATC A03AB06 (otilonium bromide), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Otilonium bromide · ATC A03AB06
2 / 19 countries
- Belgiumprice
- Czechiaprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Otilonium Bromide
- Manufacturer
- Menarini Benelux
- Country
- Belgium (BE)
- ATC code
- A03AB06
- ATC class
- Otilonium bromide
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Otilonium bromide in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainOTILONIO CINFA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Cinfa S.A.
- CzechiaSPASMOMENA. Menarini Industrie Farmaceutiche Riunite S.r.l., Florencie
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Bulgaria · Спазмомен
- Cyprus · Doralin
- Czechia · Spasmomen
- Spain · Otilonio Cinfa, Otilonio Qualigen
- Greece · Doralin, Otilax
- Croatia · Spasmomen
- Hungary · Otilonium Supremex, Spasmomen
- Italy · Obimal, Spasmomen
- Lithuania · Spasmomen
- Luxembourg · Spasmomen
- Latvia · Spasmomen
- Malta · Spasmomen
- Portugal · Spasmomen
- Romania · Spasmomen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8061bcf3-3c4b-4810-8516-f7435d05e52d GET /v1/drugs/8061bcf3-3c4b-4810-8516-f7435d05e52d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Coated tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Spasmomen 20 mg",
"name_fr": "Spasmomen 20 mg",
"name_nl": "Spasmomen 20 mg",
"amp_code": "SAM145293-00",
"strengths": [
"20.0000",
"20.0000"
],
"pack_count": 2,
"substances": [
"Otilonium Bromide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Otilonium Bromide",
"authorisation_numbers": [
"BE145293"
]
}See everything about otilonium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.